Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial

Published:2016-09-29 Issue:1 Volume:17 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Muscedere John,Maslove David,Boyd John Gordon,O’Callaghan Nicole,Lamontagne Francois,Reynolds Steven,Albert Martin,Hall Rick,McGolrick Danielle,Jiang Xuran,Day Andrew G.

Funder

John and Lotte Foundation

Queen's University

McLaughlin Center (University of Toronto)

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-016-1590-z.pdf

Reference55 articles.

1. Rosenthal V, Bijie H, Maki D, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009. Am J Infect Control. 2012;40(5):396–407.

2. Kilgore ML, Ghosh K, et al. The costs of nosocomial infections. Med Care. 2008;46(1):101–4.

3. Roberts R, Scott R, Hota B, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care. 2010;48:1026–35.

4. Eggimann P, Pittet D. Infection control in the ICU. Chest. 2001;120:2059–93.

5. Widmer A. Infection control and prevention strategies in the ICU. Intensive Care Med. 1994;20 Suppl 4:S7–11.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing the role of the FES tyrosine kinase in the pathogenesis, pathophysiology, and severity of sepsis and its outcomes;Frontiers in Immunology;2023-04-14

2. Biocides Susceptibility of Clinically Isolated Escherichia coli in Presence and Without Organic Material;Iranian Journal of Medical Microbiology;2022-09-01

3. The relationship between immune status as measured by stimulated ex-vivo tumour necrosis factor alpha levels and the acquisition of nosocomial infections in critically ill mechanically ventilated patients;Intensive Care Medicine Experimental;2020-09-16

4. Insights Into a “Negative” ICU Trial Derived From Gene Expression Profiling;Critical Care Medicine;2019-12

5. Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin;Critical Care Medicine;2018-09